Dear AuntMinnie member,
In settings with limited PET/CT availability, SPECT/CT may be a viable alternative for primary staging in patients with high-risk prostate cancer, according to a new study that attracted a lot of interest on AuntMinnie this week. Researchers concluded that Tc-99m MIP-1404 CZT SPECT/CT yielded performance that approached that of Ga-68 PSMA-11 PET/CT-CT. Access our coverage here.
Our second most viewed article this week showcased the utility of contrast-enhanced mammography (CEM) in screening women at higher risk of breast cancer.
We also featured three new podcast episodes. Fittingly for MR Safety Week, MRI safety experts and educators Tobias “Toby” Gilk and John Posh wrapped up Series 2 of The Invisible Force podcast series focusing on the death of 6-year old Michael Colombini 25 years ago. You can access that episode here.
Meanwhile, episode 14 of our Women’s Imaging MinnieCast series features a discussion with Elizabeth McDonald, MD, of the University of Pennsylvania on how GLP-1 medications may help decrease breast cancer risk. And consultant Michael J. Cannavo, AKA the PACSMan, has released episode 4 of his The PACSMan Pontificates podcast series. You can check out these and our other podcast offerings at the AuntMinnie Podcast Network.
Please see below for our other top stories of the week.
Erik L. Ridley
Editor in Chief
AuntMinnie.com
1. SPECT/CT viable over PET/CT for high-risk prostate staging
2. CEM finds breast cancer at baseline, incidence screening
3. Podcast: Testing the effectiveness of today’s MR safety standard of care
4. Women’s Imaging MinnieCast, Episode 14: GLP-1s and breast cancer risk
5. Podcast: The PACSMan Pontificates, Episode 4: The perfect PACS
6. Ablative RT shows promise in treating pancreatic cancer
7. CT radiation doses have fallen sharply over past decade
8. MRI may help predict heart disease risk in patients with diabetes
9. TACE plus thermal ablation improves survival in liver cancer
